Victoria's Secret faces fresh activist fight from Barington Capital, source says

Activist investor Barington Capital, holding over 1% of Victoria's Secret, is urging the company to overhaul its board and eliminate its recently implemented poison pill, citing a loss of over $2.4 billion in shareholder value since its 2021 spin-off; Barington believes the current board lacks sufficient experience to revitalize the brand and suggests focusing on core categories, digital growth, and international expansion, while also highlighting the potential value of the company's beauty business.

Analysis

Activist investor Barington Capital Group, which holds over 1% of Victoria's Secret & Co. (VSCO), is exerting significant pressure on the lingerie retailer to overhaul its board and rescind a "poison pill" plan adopted in May. Barington's push is fueled by VSCO's severe underperformance, highlighted by a loss of over $2.4 billion in shareholder value since its 2021 spin-off from L Brands and a stock decline exceeding 50% year-to-date. The activist fund contends that VSCO's current board and CEO Hillary Super, who reportedly took over in September 2024, lack the necessary experience for a successful brand revitalization. Barington advocates for a strategic shift towards core offerings like bras and the "Angels" campaign, coupled with accelerated growth in digital and international markets. A key assertion from Barington is the potential valuation of VSCO's beauty business, which it estimates could be equivalent to the company's entire market capitalization of approximately $1.45 billion. The defensive poison pill was implemented to counter the increased stake (around 13%) of another investment firm, BBRC International Private Limited. While VSCO's fundamental sentiment is negative (per-ticker sentiment -0.4), the news of Barington's intervention has generated a mildly positive market reaction (general sentiment 0.25), with shares rising about 3% in premarket trading, suggesting investor anticipation of potential value-unlocking changes.

Key Decisions for Investors

• Consider Barington Capital's activist campaign as a potential catalyst for change at Victoria's Secret, but weigh this against the company's documented underperformance and concerns raised about current leadership's experience.
• Monitor closely any developments regarding board composition, the potential termination of the poison pill, and shifts in corporate strategy towards Barington's suggested focus on core categories, digital acceleration, and international expansion.
• Evaluate the credibility of Barington's valuation of the beauty segment, as successful strategic initiatives to unlock this perceived value could offer considerable upside from the current market capitalization.
• Factor in Barington's mixed historical success in activist campaigns, including its prior involvement with L Brands and its unsuccessful board challenge at Matthews International, when assessing the probability of a favorable outcome at VSCO.